Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial

被引:69
作者
De Rossi, A
Walker, AS
Klein, N
De Forni, D
King, D
Gibb, DM
机构
[1] AIDS Reference Ctr, Dept Oncol & Surg Sci, Padua, Italy
[2] MRC, Clin Trials Unit, London NW1 2DA, England
[3] Inst Child Hlth, London, England
[4] Chelsea & Westminister Hosp, London, England
基金
英国医学研究理事会;
关键词
D O I
10.1086/341657
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To investigate the thymic contribution to immune reconstitution during antiretroviral therapy (ART), T cell receptor gene rearrangement excision circles (TRECs) were measured in peripheral blood mononuclear cells (PBMC) and CD4 cells from 33 human immunodeficiency virus (HIV) type 1-infected children monitored for 96 weeks after ART initiation. Baseline TREC levels were associated positively with baseline CD4 cell percentage and inversely with age and HIV-1 RNA load. During therapy, TREC level changes in PBMC and CD4 cells were fairly comparable. TREC level changes were inversely related to baseline CD4 cell percentage and positively associated with CD4 cell percentage increases, the main source being naive CD4 cells. TREC changes were independent of age and baseline HIV-1 RNA load; however, HIV-1 suppression was independently associated with smaller TREC changes. Thymic output appears to be the main source of CD4 cell repopulation in children receiving ART. Recovery of thymic function is independent of age and influenced by the status of peripheral CD4 cell depletion and HIV-1 suppression.
引用
收藏
页码:312 / 320
页数:9
相关论文
共 22 条
[1]  
Aboulker JP, 2002, LANCET, V359, P733
[2]  
[Anonymous], 1995, KENDALLS LIB STAT
[3]   Evaluation of T cell receptor gene rearrangement excision circles after antiretroviral therapy in children infected with human immunodeficiency virus [J].
Chavan, S ;
Bennuri, B ;
Kharbanda, M ;
Chandrasekaran, A ;
Bakshi, S ;
Pahwa, S .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (10) :1445-1454
[4]   Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection [J].
de Martino, M ;
Tovo, PA ;
Balducci, M ;
Galli, L ;
Gabiano, C ;
Rezza, G ;
Pezzotti, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (02) :190-197
[5]   Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection [J].
DeRossi, A ;
Masiero, S ;
Giaquinto, C ;
Ruga, E ;
Comar, M ;
Giacca, M ;
ChiecoBianchi, L .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (02) :323-330
[6]   Changes in thymic function with age and during the treatment of HIV infection [J].
Douek, DC ;
McFarland, RD ;
Keiser, PH ;
Gage, EA ;
Massey, JM ;
Haynes, BF ;
Polis, MA ;
Haase, AT ;
Feinberg, MB ;
Sullivan, JL ;
Jamieson, BD ;
Zack, JA ;
Picker, LJ ;
Koup, RA .
NATURE, 1998, 396 (6712) :690-695
[7]   Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children [J].
Essajee, SM ;
Kim, M ;
Gonzalez, C ;
Rigaud, M ;
Kaul, A ;
Chandwani, S ;
Hoover, W ;
Lawrence, R ;
Spiegel, H ;
Pollack, H ;
Krasinski, K ;
Borkowsky, W .
AIDS, 1999, 13 (18) :2523-2532
[8]  
Fessel WJ, 2000, J ACQ IMMUN DEF SYND, V23, P314
[9]  
FREDERICK T, 2000, 7 C RETR OPP INF SAN, P204
[10]   Immune repopulation after HAART in previously untreated HIV-1-infected children [J].
Gibb, DM ;
Newberry, A ;
Klein, N ;
de Rossi, A ;
Grosch-Woerner, I ;
Babiker, A .
LANCET, 2000, 355 (9212) :1331-1332